drugset / Trial / NCT00843934
Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the efficacy and safety of cisplatin (CDDP) and epirubicin (EPI) in the treatment of transcatheter chemoembolization for Hepatocellular Carcinoma (HCC).
Timeline
- Start
- 2009-03
- Primary completion
- 2012-12
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 65 mg/m2 | Other |
| Subject | Epirubicin | Small molecule | 60 mg/m2 | Other |